Detailed Review,Cyclic Citrullinated Peptide (CCP) Antibody (IgG) (11173X

The 11173 CCP cyclic citrullinated peptide Ab IgG lab code is a crucial identifier for a specific laboratory test designed to detect antibodies against cyclic citrullinated peptide (CCP), specifically the IgG isotype. This test plays a significant role in the diagnosis and management of autoimmune conditions, most notably rheumatoid arthritis (RA). Understanding the intricacies of this CCP antibody test, including its purpose, methodology, and interpretation, is vital for both healthcare professionals and patients.

The CCP antibody test is a type of blood test that measures your body's level of antibodies that commonly target specific proteins found in the joints. In the context of the 11173 CCP cyclic citrullinated peptide Ab IgG lab code, the test focuses on IgG antibodies that recognize cyclic citrullinated peptide. Citrulline is an amino acid that can become modified in the body, leading to the production of these autoantibodies in certain individuals. The cyclic citrullinated peptide itself is a synthetic peptide used as a target antigen in this immunoassay.

Several codes are associated with this test, including Test Code 11173 and Test Code 11173X. The CPT Code commonly used for this type of immunoassay is 86200. It's important to note that the specific lab code and associated billing codes can vary between different laboratory facilities. For instance, Quest Diagnostics often utilizes 11173 for this particular assay. Other related codes you might encounter include 164914, 11173 and LAB2793 for Cyclic Citrullinated Peptide (CCP) Antibodies.

The primary clinical utility of the CCP antibody test is its high specificity in aiding the diagnosis of rheumatoid arthritis (RA). While rheumatoid factor has historically been used, the anti-CCP antibody assay is often considered more sensitive and specific, particularly in the early stages of the disease. A positive result for cyclic citrullinated peptide (CCP) antibodies may be suggestive of rheumatoid arthritis (RA), especially when accompanied by compatible clinical features of the disease. In fact, the anti-CCP blood test is a diagnostic tool for detecting and monitoring RA.

Beyond diagnosis, the anti-cyclic citrullinated peptide antibody titer can also provide prognostic information. Elevated levels of anti-CCP may indicate a more aggressive disease course or a higher likelihood of developing joint erosions. This information can be valuable for tailoring treatment strategies. The cyclic citrullinated peptide ab igg test is therefore not only about identifying the presence of these antibodies but also about understanding their potential implications for disease progression.

The methodology for performing the CCP antibody test typically involves an immunoassay (IA). This technique uses specific antibodies to detect and quantify the target CCP IgG antibodies in a patient's serum sample. The result of the CCP blood test is usually reported as a numerical value, often in units like U/mL. The normal range for anti-CCP is generally considered to be less than 20 U/mL. Results at or above 20 U/mL are typically considered positive. For example, a Cyclic citrullinated peptide IgG 3.0 U/mL would generally be considered within the normal range, while higher values would warrant further investigation.

It's worth noting that while the CCP antibody test is highly indicative of RA, elevated levels might occasionally be observed in other conditions, though this is less common. The test is useful for evaluating patients suspected of having rheumatoid arthritis (RA) and differentiating it from other connective tissue diseases.

When undergoing this test, patients may inquire about how long for results. The turnaround time can vary depending on the lab and its processing capabilities, but typically results are available within a few business days.

In summary, the 11173 CCP cyclic citrullinated peptide Ab IgG lab code represents a vital diagnostic marker. This blood test for antibodies against cyclic citrullinated peptide, specifically the IgG isotype, is a cornerstone in the identification and assessment of rheumatoid arthritis, offering valuable insights for both diagnosis and prognosis. Understanding the associated codes, methodology, and interpretation of results is crucial for effective patient care.